Wilma Puijk-Van Bentum

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.

Journal: JAMA

Published: April 11, 2023

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Journal: JAMA

Published: December 16, 2022

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal: JAMA

Published: March 22, 2022

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal: JAMA

Published: October 04, 2021

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Journal: The New England journal of medicine

Published: August 05, 2021

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.

Journal: The New England journal of medicine

Published: August 05, 2021

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

Journal: The New England journal of medicine

Published: February 25, 2021

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Journal: JAMA

Published: September 03, 2020

The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design.

The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design.

Journal: Annals of the American Thoracic Society

Published: April 09, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026